Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - Re: $120M in Fees - Using last quarters license fee / revenue ratio

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Back To Forum List View

$120M in Fees - Using last quarters license fee / revenue ratio

lambertslunatics

Mar 18, 2008 09:00PM

Re: $120M in Fees - Using last quarters license fee / revenue ratio

HUNTINGTON-L

Mar 18, 2008 09:24PM

BaNosser

Rank: President [?]

Points: 24217 [?]

Votes: 157 Score: 3.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: $120M in Fees - Using last quarters license fee / revenue ratio

in response to

$120M in Fees - Using last quarters license fee / revenue ratio

lambertslunatics

posted on Mar 18, 2008 10:20PM

yep

Re: $120M in Fees - Using last quarters license fee / revenue ratio

patricklaurin

Apr 07, 2008 01:18PM

Re: $120M in Fees - Using last quarters Lambert

billwilke

Apr 07, 2008 01:27PM

Reply New Message

Back To Forum List View

Please to post a reply